| Page 337 | Kisaco Research
 

Lisa Suennen

Managing Partner, AHA Ventures
American Heart Association

Lisa Suennen

Managing Partner, AHA Ventures
American Heart Association

Lisa Suennen

Managing Partner, AHA Ventures
American Heart Association
 

Jason Roberts

Gynecological and Surgical Devices, CDRH,
FDA

Jason Roberts

Gynecological and Surgical Devices, CDRH,
FDA

Jason Roberts

Gynecological and Surgical Devices, CDRH,
FDA
 

Patricia Obermaier

Chief Growth Officer, Global Health and Life Sciences
Microsoft

Patricia Obermaier

Chief Growth Officer, Global Health and Life Sciences
Microsoft

Patricia Obermaier

Chief Growth Officer, Global Health and Life Sciences
Microsoft
 

Nichole YoungLin

MD, MBA, Women’s Health Clinical Lead
Google

Nichole YoungLin

MD, MBA, Women’s Health Clinical Lead
Google

Nichole YoungLin

MD, MBA, Women’s Health Clinical Lead
Google
 

Monica Garcia

Assistant Director, Obstetrical and Reproductive Health Devices Team, CDRH,
FDA

Monica Garcia

Assistant Director, Obstetrical and Reproductive Health Devices Team, CDRH,
FDA

Monica Garcia

Assistant Director, Obstetrical and Reproductive Health Devices Team, CDRH,
FDA
 

Shefali Goyal MS, MSc

Vice President, Head of Global RA Strategy and US Regulatory Affairs
Organon

Shefali Goyal MS, MSc

Vice President, Head of Global RA Strategy and US Regulatory Affairs
Organon

Shefali Goyal MS, MSc

Vice President, Head of Global RA Strategy and US Regulatory Affairs
Organon
 

Hadine Joffee

MD, MSc, Interim Chair, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women's Health and Gender Biology
Brigham and Women’s Hospital & Harvard Medical School

Hadine Joffee

MD, MSc, Interim Chair, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women's Health and Gender Biology
Brigham and Women’s Hospital & Harvard Medical School

Hadine Joffee

MD, MSc, Interim Chair, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women's Health and Gender Biology
Brigham and Women’s Hospital & Harvard Medical School
 

Jennifer Schneiders

President Diagnostic Solutions
Hologic

Jennifer Schneiders

President Diagnostic Solutions
Hologic

Jennifer Schneiders

President Diagnostic Solutions
Hologic
 

Diane Gabl Kratz

Director, IP Strategy & Operations
Dolby

Diane is a four-time IAM Strategy 300 World's Leading IP Strategist and USPTO-registered patent attorney. At Dolby, she leads an 18-person global team, developing and executing U.S. and international patent filing strategies and heading Dolby’s worldwide trademark portfolio. A four-time Super Lawyers Rising Star, she began in IP litigation at international law firms Morrison & Foerster and Sidley Austin. 

Read full bio

Diane Gabl Kratz

Director, IP Strategy & Operations
Dolby

Diane Gabl Kratz

Director, IP Strategy & Operations
Dolby

Diane is a four-time IAM Strategy 300 World's Leading IP Strategist and USPTO-registered patent attorney. At Dolby, she leads an 18-person global team, developing and executing U.S. and international patent filing strategies and heading Dolby’s worldwide trademark portfolio. A four-time Super Lawyers Rising Star, she began in IP litigation at international law firms Morrison & Foerster and Sidley Austin. 

Diane frequently presents at conferences throughout the U.S. and has guest lectured at Stanford, University of California-Berkeley’s Haas School of Business, and serves as regular faculty at PLI. She has been quoted or profiled in numerous legal publications including Law360, American Lawyer/Law.com, IAM, and Managing IP. She is a Founding Board Member of the California IP Alliance. Diane received her J.D. from the University of Chicago and a Physics degree from Cornell University.

Generative AI
AI Infrastructure
Systems

Author:

Galina Sagan

Prinicpal
Hitachi Ventures

Galina Sagan is a Principal at Hitachi Ventures, a global venture fund (with >600m USD AUM) with Hitachi being a single LP. Galina specializes in Enterprise SaaS B2B and digital investments. Some of the relevant deals include Trustwise AI, Archetype AI, Rescale and WekaIO. Formerly a Senior Investment Associate at Speedinvest, a pan-European early stage fund with > €1 billion AUM.

Galina has been recognized as one of GCVs Rising Stars in 2022.

... read more

Galina Sagan

Prinicpal
Hitachi Ventures

Galina Sagan is a Principal at Hitachi Ventures, a global venture fund (with >600m USD AUM) with Hitachi being a single LP. Galina specializes in Enterprise SaaS B2B and digital investments. Some of the relevant deals include Trustwise AI, Archetype AI, Rescale and WekaIO. Formerly a Senior Investment Associate at Speedinvest, a pan-European early stage fund with > €1 billion AUM.

Galina has been recognized as one of GCVs Rising Stars in 2022.

Author:

Kai Zenner

Head of Office, Digital Policy Advisor
European Parliament
... read more

Kai Zenner

Head of Office, Digital Policy Advisor
European Parliament